title: In vivo distribution of lead in male and female rats after intraperitoneal and oral administration.
abstract: The resultant effects of lead exposure are seen in almost all the systems of the body and results in toxicity to many organs. Since toxicity depends on its degree of uptake, distribution and metabolism, the authors investigated the differential uptake, accumulation and distribution of lead in organs of males and female Wistar rats following various routes of administration. Group 1 served as control male and control female; group 2 males and females received 5 mg/kg body weight of lead intraperitoneally for 8 days while group 3 males and female rats were administered drinking water containing 100 ppm of lead acetate for 18 days. Tissues were collected for analysis of the lead content using atomic absorption spectroscopy. The relative retention of lead by the tissues was greater in rats exposed to lead by the i.p. route varying in the order of accumulation / uptake in males as lungs > spleen > stomach > kidney > blood > heart and in females as spleen > stomach > heart > kidney > blood > lungs (i.p. route) and (oral route) as for males kidney > lungs > stomach > blood > heart > spleen, and females as kidney > lungs > stomach > blood > heart > spleen. Male Wistar rats showed more accumulation with oral exposure in lungs, spleen and blood with values for kidney and stomach being significantly (p < 0.05) higher when compared with females. Female Wistar rats showed more accumulation with i.p. exposure for spleen and stomach tissues while values for the heart was significantly (p < 0.05) higher than the males. Our findings suggest that lead retention and the organ distribution varied depending upon the sex and route of lead administration.
authors.affiliation: Department of Basic Medical Sciences, University of the West Indies Mona Jamaica, West Indies. chukwuemeka.nwokocha@uwimona.edu.jm
authors.forename: C R
authors.initials: CR
authors.lastname: Nwokocha
authors.forename: C S
authors.initials: CS
authors.lastname: Ufearo
authors.forename: D U
authors.initials: DU
authors.lastname: Owu
authors.forename: N C
authors.initials: NC
authors.lastname: Idemudo
authors.forename: L C
authors.initials: LC
authors.lastname: Ojukwu
mesh_terms: D000284:Administration, Oral; D000818:Animals; D005260:Female; D007274:Injections, Intraperitoneal; D007854:Lead / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D014018:Tissue Distribution
chemical_list: D009942:Organometallic Compounds; D007854:Lead; C008261:lead acetate